1. Introduction -spelling of the title to be corrected -add the conversion to mg for penicillin (e.g. 50,000 units = 30mg) 2. Methods -further clarify the inclusion criteria of -it is noted that four specific contaminants are excluded from analysis, which is fine, although it may be important to note somewhere that CONS (particularly S. epidermidis) can be pathogenic and cause clinically significant morbidity and mortality in some patient populations, particularly the premature infant 3. Results -'Organisms isolated': line 3, remove the words 'The remaining' - Table 1 : it may be useful to note that the overall percentage of pathogens isolated (as a proportion of the total blood cultures performed) has dropped annually from 2002 to 2007 (18.1%, 15.2%, 11.9%, 11.2%, 10.6%, 10.2%), thus although the percentage of resistant organisms has risen since the previous audit (1996) (1997) (1998) (1999) (2000) (2001) , there is likely to be a treatment effect overall -whether this is due to general standards of hygiene and nursing/medical care, or to institution of a standardised antibiotic treatment regimen is difficult to quantify -Antibiotic susceptibility: although the point is made that resistance percentages did not change dramatically from pre-2006 (when cultures were done at commencement of therapy) to 2006 onwards (when cultures were done after failure of first line therapy), one must use the resistance of individual organisms that would normally be sensitive to these first line medications (e.g. the E coli data presented in paragraph 2) to further explore this phenomenon. Otherwise, it may be assumed that the similar resistance rates with lower positive culture rates is a reflection of selection bias (fewer more 'common' susceptible organisms grown in the era of cultures being done after first line therapy) rather than failure of first line therapy -this could perhaps be explored in the discussion a little further -it is noted that only 2% of staphylococci were resistant to cloxacillin. In the Discussion (Isolated organisms) they then go on to mention that separating community-from hospital-acquired infections remains difficult due to not being able to track place or time of birth. It is noted, however, in the Results (Organisms isolated), that samples were collected from the main nursery (mainly outborns) and the special care baby unit (inborns and direct transfers). Thus stratifying results with the main nursery versus special care baby unit may help further delineate this issue and allow possible changes to antibiotic regimens for different patients groups. Once again, this could be looked at in the discussion a little more.
4. Discussion -Isolated organisms: it is noted that the proportions of G+ to Gorganisms (53/47%) is in contrast to data from other African areas, although it is not mentioned that when cultures were taken after first line therapy, this trend actually reversed in the current study.
-Antibiotic resistance and implications for empirical treatment: the authors note the trend towards ceftriaxone resistance -it may be useful to add a statement about the emerging use of third generation cephalosporins at QECH in this time as a possible explanation (i.e. this is not 'de novo').
-Limitations: it is noted that isolates taken after policy change may reflect organisms that grow, and another reason that could be mentioned as a cause for the ongoing high rates of resistant organisms is that these children have been in a hospital environment for at least 48 hours before a culture is taken, thus exposing them to nosocomial infections, which are generally more resistant.
Conclusions:
-perhaps some more emphasis on this review highlighting the relevance and importance of thoroughly assessing local microbiological data in the era of more universal treatment recommendations being adopted (this could even be added to the abstract?) Dr David Tickell MBBS FRACP Consultant Paediatrician, Ballarat Health Services, Australia
Competing interests: I worked as a paediatrician at QECH in Malawi from [2007] [2008] . I acted as a supervisor for the primary author, Dr Gwee, during her subsequent training in Australia. Q. add the conversion to mg for penicillin (e.g. 50,000 units = 30mg) A. We have added this: "Septic infants aged 60 days or less are treated with parenteral penicillin (50,000 units or 30mg per kg three or four times daily)…" 2. Methods Q. further clarify the inclusion criteria of -it is noted that four specific contaminants are excluded from analysis, which is fine, although it may be important to note somewhere that CONS (particularly S. epidermidis) can be pathogenic and cause clinically significant morbidity and mortality in some patient populations, particularly the premature infant.
REVIEWER
A. We agree with the reviewer that CoNS can be pathogenic for such infants, in particular premature infants with central venous access. The second reviewer, Dr Vergnano, also raised this point. While it is possible that there is an overall treatment effect operating over the six years as proposed by the reviewer, the change in policy appears to have quickly altered the proportions. We suggest that the lower proportion of cultures that grew pathogens in 2006 and 2007 has occurred because the policy has selected:
(1) Children whose clinical improvement lags behind microbiological clearance -they no longer have a bacteraemia because first line therapy has cleared the blood of organisms but clinical response is slower prompting clinicians to take cultures (2) Children whose symptoms were due to fastidious organisms (3) Children whose symptoms were due to a non-bacterial cause
We have added two sentences to the Discussion to note these possibilities: "The 2006 policy to take blood cultures only when first-line therapy failed led to relatively fewer pathogens cultured overall and more Gram-negative isolates. This is likely a function of selecting children whose symptoms were due to fastidious organisms and non-bacterial causes as well as those whose clinical improvement lagged behind their microbiological improvement (i.e. they still had symptoms but no bacteraemia)."
Q. Antibiotic susceptibility: although the point is made that resistance percentages did not change dramatically from pre-2006 (when cultures were done at commencement of therapy) to 2006 onwards (when cultures were done after failure of first line therapy), one must use the resistance of individual organisms that would normally be sensitive to these first line medications (e.g. the E coli data presented in paragraph 2) to further explore this phenomenon. Otherwise, it may be assumed that the similar resistance rates with lower positive culture rates is a reflection of selection bias (fewer more 'common' susceptible organisms grown in the era of cultures being done after first line therapy) rather than failure of first line therapy -this could perhaps be explored in the discussion a little further A. Below are tables of sensitivity to first-line therapy for some of the most common organisms grown in the period of study. Sensitivity to first-line therapy was the same or higher from 2006 onwards though there were far fewer organisms in 2006 and 2007 compared to earlier years. These data for individual organisms support the overall conclusion that antibiotic resistance did not change after the change in policy. It could be that many cultures were taken from children whose fever was slow to abate but whose infection was nonetheless sensitive to first-line treatment.
While we did not detect a difference in resistance to first-line therapy between the periods 2002-05 and 2006-07, we did find that resistance was higher in 2007 compared to 2002 , that Gram-negative organisms were more common in 2007 than in 2002, and that resistance to gentamicin was much higher in 2007 than in 2002. It could be that these differences will become more apparent over time and may come to characterise the new policy of blood culture taking.
Proportion of common isolates sensitive to first line therapy, 2002-07
Q. it is noted that only 2% of staphylococci were resistant to cloxacillin. In the Discussion (Isolated organisms) they then go on to mention that separating community-from hospital-acquired infections remains difficult due to not being able to track place or time of birth. It is noted, however, in the Results (Organisms isolated), that samples were collected from the main nursery (mainly outborns) and the special care baby unit (inborns and direct transfers). Thus stratifying results with the main nursery versus special care baby unit may help further delineate this issue and allow possible changes to antibiotic regimens for different patients groups. Once again, this could be looked at in the discussion a little more. A. Unfortunately, wards are not direct surrogates for those born inside and outside the hospital; rather, both wards include a mix of children born in and outside the hospital (e.g. the main nursery has infants that may have been born in the QECH, discharged and then readmitted). As such, we do not have mutually exclusive strata representing inborns and outborns, and so have not presented analyses of these data. We have edited the text in the second sentence of the results so readers are aware of this:
"Fifty-five percent (3,726) were collected from inpatients of the main paediatric nursery that were mostly born outside the hospital; 40% (2,673) were from infants in the special care baby unit who were born at the QECH or in another health care facility and transferred directly to this unit."
We agree with the reviewer that information about inborns versus outborns may assist in developing more targeted antibiotic regimens, and we had drawn attention to this in our conclusion:
"Audits should ideally be correlated with clinical outcomes and separate community-acquired from hospital acquired infections to determine the most appropriate first line antibiotic regimens."
4. Discussion Q. Isolated organisms: it is noted that the proportions of G+ to G-organisms (53/47%) is in contrast to data from other African areas, although it is not mentioned that when cultures were taken after first line therapy, this trend actually reversed in the current study.
A. This point has been included by rewriting the Results as follows: We have also noted this in the Discussion:
"The 2006 policy to take blood cultures only when first-line therapy failed led to relatively fewer pathogens cultured overall. This is likely a function of selecting children whose symptoms were due to fastidious organisms and non-bacterial causes as well as those whose clinical improvement lagged behind their microbiological improvement (i.e. they still had symptoms but no bacteraemia). The policy change also led to more Gram-negative isolates that may reflect a reduced susceptibility of Gramnegative organisms to first line antibiotics as was seen in 2007 compared with 2002."
Q. Antibiotic resistance and implications for empirical treatment: the authors note the trend towards ceftriaxone resistance -it may be useful to add a statement about the emerging use of third generation cephalosporins at QECH in this time as a possible explanation (i.e. this is not 'de novo'). A. We have added to the sentence in the Discussion on ceftriaxone resistance to note the fact that this agent is used when empirical treatment fails:
"It is also important to note the worrying shift towards resistance to ceftriaxone, which had not been present earlier and has emerged with the increasing use of ceftriaxone as second-line therapy."
Q. Limitations: it is noted that isolates taken after policy change may reflect organisms that grow, and another reason that could be mentioned as a cause for the ongoing high rates of resistant organisms is that these children have been in a hospital environment for at least 48 hours before a culture is taken, thus exposing them to nosocomial infections, which are generally more resistant.
A. The impact of length of stay is already noted in the Limitations -"Length of stay, which has been associated with nosocomial spread of pathogens with higher levels of antibiotic resistance, was not recorded in our dataset." Consequently, we have elected not to change or add to this.
Conclusions:
Q. perhaps some more emphasis on this review highlighting the relevance and importance of thoroughly assessing local microbiological data in the era of more universal treatment recommendations being adopted (this could even be added to the abstract?). A. We have added a line after the opening sentence of the conclusions to reflect this point:
"This study is one of the largest single site studies of its kind in developing countries and highlights the importance of local aetiological assessments of young infant sepsis for review of empiric treatment. Arguably, such assessments are becoming more important as standard treatment recommendations from international bodies are increasingly applied."
Reviewer: Stefania Vergnano, Paediatric Registrar, Imperial College, London, UK Q1. Would be important to discuss the dose of gentamicin. WHO recommends 3 mg/kg/day or 5 mg/kg/day for low birth weight and normal birth weight babies respectively in the first 2 weeks of life and 7.5 mg/kg/day for infants above 2 weeks of age. It would be interesting to know why the 6 mg/kg/day was chosen in QEQM. A1. Unfortunately, there is no evidence based rational for this dosing regimen. The dosing policy at QECH has been 6mg/kg/day for many years. We have added a few words in the introduction to reflect this:
"Septic infants aged 60 days or less are treated with parenteral penicillin (50,000 units or 30mg per kg three or four times daily) and gentamicin (6 mg/kg/day) as per hospital policy."
Q2. Q6. Page 15 line 20-22 "Some laboratory … single dose course" I found this sentence difficult to read and had to look at it several times, maybe it is possible to express the concept more clearly? A6. We have revised the sentence to read:
"Some laboratory based surveillance systems recommend revising treatment when more than 5% of isolates have in vitro resistance to a particular antibiotic (20)."
Q7. Would be interesting to know what the author think about the fact that the change in policy in 2006 did not impact on the level of resistance to first line therapy. It would be expected an higher resistance in this new A7. The timing of culture taking is a key variable that was not in our dataset and may have influenced these findings. For instance, if cultures were taken quite soon after antibiotics were commenced (e.g. 24 hours), children may still have had a bacteraemia of organisms that were in fact sensitive to firstline therapy.
As indicated by reviewer 1 and in our response to reviewer 1, the shift in organism type after the new policy was instituted selected for relatively more Gram-negative organisms. It might be that Gramnegative organisms cause a comparatively longer bacteraemia in the presence of effective antibiotic treatment.
On the other hand, the big differences between 2002 and 2007 (more gram-negative organisms, more gentamicin resistance, more overall resistance to first-line therapy) may be more characteristic of the impact of the policy change and we may see this pattern more clearly emerge if we continue to track resistance into the future. 
VERSION 2 -REVIEW

REVIEWER
GENERAL COMMENTS
Minor spelling changes: -p8 Antibiotic susceptibility: first line should read "tested isolates were resistant" -p13 Discussion: first line of third paragraph should read "infants aged 28-60 days, a finding" -p14 Antibiotic resistance and implications: second line of second paragraph should read "Gram-negative organisms, in particular"
